The estimated Net Worth of Partners L P/Ilbiotechnolog... is at least $237 Milión dollars as of 26 November 2013. Partners Ilbiotechnolog owns over 527,505 units of Ligand Pharmaceuticals stock worth over $207,090,697 and over the last 12 years Partners sold LGND stock worth over $30,210,211.
Partners has made over 2 trades of the Ligand Pharmaceuticals stock since 2013, according to the Form 4 filled with the SEC. Most recently Partners sold 527,505 units of LGND stock worth $30,210,211 on 26 November 2013.
The largest trade Partners's ever made was selling 527,505 units of Ligand Pharmaceuticals stock on 26 November 2013 worth over $30,210,211. On average, Partners trades about 283,553 units every 154 days since 2013. As of 26 November 2013 Partners still owns at least 2,008,834 units of Ligand Pharmaceuticals stock.
You can see the complete history of Partners Ilbiotechnolog stock trades at the bottom of the page.
Over the last 21 years, insiders at Ligand Pharmaceuticals have traded over $205,340,014 worth of Ligand Pharmaceuticals stock and bought 2,116,600 units worth $27,601,439 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Partners L P/Ilbiotechnolog... a Partners L P/Ilbiotechnolog.... On average, Ligand Pharmaceuticals executives and independent directors trade stock every 22 days with the average trade being worth of $2,239,733. The most recent stock trade was executed by Octavio Espinoza on 28 August 2024, trading 753 units of LGND stock currently worth $50,090.
ligand, a pharmaceutical company, is assembling a large and diverse portfolio of current and near-term commercial revenue generating assets to assist the long-term financial growth of the company. we operate this business on a lean cost structure that allows us to maximize cash flow and ultimately deliver a meaningful return for our shareholders.
Ligand Pharmaceuticals executives and other stock owners filed with the SEC include: